SDG indicator 3.b.3 - an analysis of its robustness and challenges for measuring access to medicines for children
Abstract Background Sustainable Development Goal (SDG) indicator 3.b.3 monitors progress in medicines' accessibility for adults and has significant limitations when applying to medicines for children. An adapted indicator methodology was developed to fill this gap, but no proof of its robustnes...
Saved in:
Main Authors: | I. R. Joosse (Author), V. J. Wirtz (Author), A. T. van Mourik (Author), B. A. Wagner (Author), A. K. Mantel-Teeuwisse (Author), F. Suleman (Author), H. A. van den Ham (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2023-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Monitoring Access to Child Medicines: Introducing a Standardized Set of Age-Appropriate Medicines
by: Iris R. Joosse, et al.
Published: (2024) -
Access to childhood cancer medicines in South Africa: a health systems analysis of barriers and enablers
by: Iris R. Joosse, et al.
Published: (2024) -
The caregiver's experience of childhood cancer treatment in South Africa
by: I. R. Joosse, et al.
Published: (2024) -
Editorial: Addressing contemporary public health challenges in Ghana for improved outcomes: getting to SDG 3
by: Delanyo Dovlo, et al.
Published: (2024) -
Evaluation of alignment of the reimbursement medicines list for children in Albania with the WHO essential medicines list for children
by: E. Petro, et al.
Published: (2024)